Abiopharma

SeaStar Medical - SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Reports Update on Nasdaq Listing Status

OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting Strategic Progress

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Ovid Therapeutics Inc. - Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties

Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500

SenesTech and Irvine Campus Housing Authority Conclude Successful Field Trial of Evolve™ Rat Birth Control at UC Irvine

Amneal Pharmaceuticals, Inc. - Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

New Form 424B5 - SenesTech, Inc. Filed: 2025-06-25 AccNo: 0001213900-25-057475 Size: 370 KB

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting

Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025